NCT02926521

Brief Summary

The investigators' objective is to evaluate whether any of the various peripheral nerve block catheter dressing strategies currently employed by the Boston Children's Hospital Regional Anesthesia Service has any differential impact on specific outcome endpoints such as regional block catheter dislodgement, catheter occlusion, catheter leakage, skin irritation, and skin infection.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Dec 2021

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 4, 2016

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 6, 2016

Completed
5.2 years until next milestone

Study Start

First participant enrolled

December 1, 2021

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2023

Completed
Last Updated

February 10, 2022

Status Verified

January 1, 2022

Enrollment Period

1.5 years

First QC Date

October 4, 2016

Last Update Submit

January 27, 2022

Conditions

Keywords

nerve block cathetercatheter fixationcatheter dressing

Outcome Measures

Primary Outcomes (1)

  • nerve block catheter dislodgement

    presence or absence of catheter dislodgement (catheter out or no longer in a clinically effective position)

    duration of catheter use, up to but not longer than, 1 week

Secondary Outcomes (4)

  • nerve block catheter occlusion

    duration of catheter use, up to but not longer than, 1 week

  • nerve block catheter leakage

    duration of catheter use, up to but not longer than, 1 week

  • skin irritation at site of nerve block catheter skin entry

    duration of catheter use, up to but not longer than, 1 week

  • catheter site infection

    duration of catheter use, up to but not longer than, 1 week

Study Arms (4)

Dressing A

NO INTERVENTION

Dressing A: a nerve block catheter affixed with Pajunk anchor and covered with Tegaderm.

Dressing B

ACTIVE COMPARATOR

Dressing B: a nerve block catheter affixed with Pajunk anchor, skin treated with gum mastic liquid adhesive (Mastisol), all covered with Tegaderm

Device: Gum Mastic

Dressing C

ACTIVE COMPARATOR

Dressing C: a nerve block catheter sealed with 2-octyl cyanoacrylate liquid adhesive (Dermabond), trailing catheter affixed with Pajunk anchor, all covered with Tegaderm

Device: 2-octyl cyanoacrylate

Dressing D

ACTIVE COMPARATOR

Dressing D: a nerve block catheter sealed with 2-octyl cyanoacrylate (Dermabond), trailing catheter affixed with Pajunk anchor, skin treated with gum mastic liquid adhesive (Mastisol), all covered with Tegaderm

Device: 2-octyl cyanoacrylateDevice: Gum Mastic

Interventions

Addition of 2-octyl cyanoacrylate liquid adhesive to nerve catheter dressing

Also known as: Dermabond
Dressing CDressing D

Addition of gum mastic liquid adhesive to nerve catheter dressing

Also known as: Mastisol Liquid Adhesive
Dressing BDressing D

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • all subjects who are 0-100 years of age who are scheduled to receive a PNB catheter of one of the following types:
  • lumbar plexus
  • paravertebral
  • femoral
  • sciatic
  • brachial plexus (infraclavicular, supraclavicular and interscalene approach)
  • TAP (transversus abdominis plane)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Boston Children"S Hospital

Boston, Massachusetts, 02118, United States

Location
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Instructor

Study Record Dates

First Submitted

October 4, 2016

First Posted

October 6, 2016

Study Start

December 1, 2021

Primary Completion

June 1, 2023

Study Completion

June 1, 2023

Last Updated

February 10, 2022

Record last verified: 2022-01

Data Sharing

IPD Sharing
Will not share

Locations